Indivior Resolves Patent Disputes With Actavis
By Najat Kantouar Indivior said it has reached an agreement with Actavis Laboratories UT to resolve patent disputes regarding Actavis's Abbreviated New Drug...
Source: marketwatch.com
Actavis Laboratories News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Actavis Laboratories. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Actavis Laboratories Today - Breaking & Trending Today
Indivior Settles Patent Dispute With Teva Unit
Indivior PLC (INDV, INDV.L) announced that its subsidiaries Indivior Inc. and Indivior UK, entered into a settlement agreement with Actavis Laboratories UT, a unit of Teva Pharmaceuticals, to resolve patent disputes regarding Actavis's Abbreviated New Drug Application for generic buprenorphine and naloxone sublingual film.
Source: rttnews.com
Indivior agrees settlement with Actavis over patent dispute
Indivior PLC - Richmond, Virginia-based pharmaceutical firm - Says its subsidiaries Indivior Inc and Indivior UK Ltd has agreed on a settlement deal with Actavis Laboratories UT Inc, a subsidiary of...
Source: marketscreener.com
Two-month-long U.S. Market Rally Extend 2023 Gains
Fundamental data and tools for long term investing, research and analysis for U.S. stocks, economy and indexes.
Source: ticker.com